Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Linda J. Stuckey"'
Autor:
Katrina Ford, Lisa Peters, Kyle L. Dawson, Tara Miller, A. Cochrane, Reda E. Girgis, Linda J. Stuckey, H. Lyster, Doug Jennings, Michelle M. Kittleson, Phillip Weeks, Stuart D. Russell, T. Tse, Janet Scheel, Maureen Flattery, Monica Colvin, Christina T. Doligalski, Robert L. Page, M. Shullo, Steven Ivulich, Tamara Claridge, Martin Schweiger, C. Yost, Kathleen E. Simpson, JoAnn Lindenfeld, T. Khuu, Christopher R. Ensor, David Weill, Anne I. Dipchand, David A. Baran, Patricia A. Uber
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:1050-1069
In 2009, the International Society for Heart and Lung Transplantation recognized the importance and challenges surrounding generic drug immunosuppression. As experience with generics has expanded and comfort has increased, substantial issues have ari
Publikováno v:
Transplantation. 100:1815-1826
Invasive fungal infection remains a serious postoperative complication in lung transplant recipients and is associated with significant morbidity and mortality. Although most lung transplant centers use antifungal prophylaxis, consensus on the strate
Autor:
Susan Murray, Irina Degtiar, Stijn E. Verleden, Elizabeth A. Belloli, Craig J. Galbán, Ella A. Kazerooni, Linda J. Stuckey, Vibha N. Lama, Gregory A. Yanik, Xin Wang, Brian D. Ross
Publikováno v:
American journal of respiratory and critical care medicine
Rationale: The predominant cause of chronic lung allograft failure is small airway obstruction arising from bronchiolitis obliterans. However, clinical methodologies for evaluating presence and degree of small airway disease are lacking. Objectives:
Publikováno v:
American Journal of Health-System Pharmacy. 69:340-347
Purpose The value of a transplantation specialty pharmacy (TSP) program, including its impact on patient and health care provider satisfaction, selected clinical outcomes, and the institution’s financial margin, was evaluated. Methods Patient and h
Autor:
Linda J. Stuckey, N.M. Walker, Diane C. Fingar, Elizabeth A. Belloli, Andrew C. Chang, Serina M. Mazzoni, Kevin M. Chan, William R. Lynch, Vibha N. Lama, Jules Lin
Publikováno v:
The Journal of biological chemistry. 291(12)
Fibrotic diseases display mesenchymal cell (MC) activation with pathologic deposition of matrix proteins such as collagen. Here we investigate the role of mTOR complex 1 (mTORC1) and mTORC2 in regulating MC collagen expression, a hallmark of fibrotic
Publikováno v:
Open Forum Infectious Diseases
Background GCV-R CMV infection is an emerging cause of morbidity and mortality in lung transplant recipients. The purpose of this study was to evaluate the clinical and economic impact of GCV-R CMV infection in a high-risk population. Methods We perf
Publikováno v:
Therapeutic drug monitoring. 36(2)
BACKGROUND Lung transplantation is an established treatment for cystic fibrosis (CF) patients with end-stage lung disease. Current immunosuppression includes the prodrug mycophenolate mofetil (MMF), which has led to improved transplant outcomes. Give
Autor:
A. Heinle, Jules Lin, R.L. Sagana, Kevin M. Chan, Andrew C. Chang, Linda J. Stuckey, J. Berry, D. Stepka, H. Collins, L. Roaden
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S228
of preoperative extracorporeal life support (ECLS). With such criteria, 42 patients had an initial indication for HLT, but only 30 received HLT (Gr 1 HLT/HLT); 32 patients received DLT as initially indicated (Gr 2 DLT/DLT). Twelve patients initially
Autor:
Linda J, Stuckey, Malek, Kamoun, Anish, Wadhwa, Millie, Samaniego, Cathy, Bartos, Jennifer, Berry, Raja, Mahidhara, Andrew C, Chang, Kevin M, Chan
Publikováno v:
Clinical transplants.
Publikováno v:
Transplantation. 89(8)
Abnormal glucose metabolism (AGM) is common early after kidney transplantation and is a risk factor for new-onset diabetes after transplant (NODAT) (1, 2). The majority of NODAT occurs early after kidney transplantation, and it is associated with inc